Skip to main content

and
  1. No Access

    Article

    Combining method of detection and 70-gene signature for enhanced prognostication of breast cancer

    Studies have shown that screen detection by national screening programs is independently associated with better prognosis of breast cancer. The aim of this study is to evaluate the association between tumor bi...

    J. M. N. Lopes Cardozo, M. K. Schmidt in Breast Cancer Research and Treatment (2021)

  2. Article

    Open Access

    Enrichment of high-grade tumors in breast cancer gene expression studies

    Gene expression (GE) profiling for breast cancer classification and prognostication has become increasingly used in clinical diagnostics. GE profiling requires a reasonable tumor cell percentage and high-quali...

    M. van Seijen, A. L. Mooyaart, L. Mulder in Breast Cancer Research and Treatment (2018)

  3. Article

    Erratum to: Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis

    C. A. Drukker, S. G. Elias, M. V. Nijenhuis in Breast Cancer Research and Treatment (2015)

  4. No Access

    Article

    Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis

    The 70-gene signature (MammaPrint™) has been developed to predict the risk of distant metastases in breast cancer and select those patients who may benefit from adjuvant treatment. Given the strong association...

    C. A. Drukker, S. G. Elias, M. V. Nijenhuis in Breast Cancer Research and Treatment (2014)

  5. Article

    Open Access

    Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms

    Clinical guidelines for breast cancer treatment differ in their selection of patients at a high risk of recurrence who are eligible to receive adjuvant systemic treatment (AST). The 70-gene signature is a mole...

    C. A. Drukker, M. V. Nijenhuis in Breast Cancer Research and Treatment (2014)

  6. Article

    Open Access

    Long-term impact of the 70-gene signature on breast cancer outcome

    Several studies have validated the prognostic value of the 70-gene prognosis signature (MammaPrintR), but long-term outcome prediction of these patients has not been previously reported. The follow-up of the cons...

    C. A. Drukker, H. van Tinteren, M. K. Schmidt in Breast Cancer Research and Treatment (2014)

  7. Article

    Open Access

    Mammographic screening detects low-risk tumor biology breast cancers

    Overdiagnosis of breast cancer, i.e. the detection of slow-growing tumors that would never have caused symptoms or death, became more prevalent with the implementation of population-based screening. Only rough...

    C. A. Drukker, M. K. Schmidt, E. J. T. Rutgers in Breast Cancer Research and Treatment (2014)